Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in ...

Investigators said patients experienced adverse effects in line with those expected for myeloablative conditioning with ...

In the assessment of 12-month price targets, analysts unveil insights for Voyager Therapeutics, presenting an average target ...

“One key difference in cell and gene therapy deals is that companies prefer ... in a collaboration network of global R&D on monoclonal antibodies, mAB’s, 2017, 9,7, 1041-1051.

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

Wedbush started coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report issued on Friday morning, ...

Find out about the evolution of healthcare from historical challenges to modern innovations. Learn how technology like AI, ...

Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics ...

The North Carolina Biotechnology Center has announced the inaugural class of Pfizer-NCBiotech Distinguished Postdoctoral Fellows in Gene Therapy. The Fellows include Adrian Pickar and Hye Ri Kang of ...

With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ...

Gene therapy involves the introduction of new genes into cells, to restore or add gene expression, for the purpose of treating disease. Most commonly a mutated gene is replaced with DNA encoding a ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).